Luyster Faith S, Kip Kevin E, Buysse Daniel J, Aiyer Aryan N, Reis Steven E, Strollo Patrick J
School of Nursing, University of Pittsburgh, Pittsburgh, PA.
College of Nursing, University of South Florida, Tampa, FL.
Sleep. 2014 Mar 1;37(3):593-600. doi: 10.5665/sleep.3506.
Insomnia and sleep apnea frequently co-occur and are independently associated with an increased risk of cardiovascular disease, but little is known about cardiovascular disease risk among individuals with comorbid insomnia and sleep apnea. The current study examined traditional risk factors and a physiologic biomarker of cardiovascular risk in comorbid insomnia and sleep apnea.
Community-based participatory research study.
The sample comprised 795 participants without preexisting cardiovascular disease from the Heart Strategies Concentrating On Risk Evaluation (Heart SCORE) study.
Participants were assessed for symptoms of insomnia and sleep apnea risk, as well as for presence of obesity, smoking, a sedentary lifestyle, hypertension, dyslipidemia, and diabetes. Baseline resting brachial artery diameter was measured by B-mode ultrasonography. A total of 138 participants (17.4%) met criteria for insomnia syndrome alone, 179 (22.5%) were at high risk for sleep apnea alone, 95 (11.9%) reported both insomnia syndrome and high sleep apnea risk, and 383 (48.2%) reported having neither insomnia nor sleep apnea symptoms Both high sleep apnea risk alone and comorbid insomnia and high sleep apnea risk groups had greater frequencies of obesity, sedentary lifestyle, hypertension, and three or more traditional cardiovascular risk factors and significantly larger brachial artery diameters than the insomnia alone group and those without insomnia or sleep apnea symptoms. No differences in traditional cardiovascular risk factors or brachial artery diameter were found between the high sleep apnea risk and comorbid groups.
These findings suggest that sleep apnea is a major contributor to cardiovascular risk and co-occurring insomnia does not appear to add to this risk.
失眠与睡眠呼吸暂停常同时出现,且均与心血管疾病风险增加独立相关,但对于合并失眠和睡眠呼吸暂停的个体的心血管疾病风险知之甚少。本研究调查了合并失眠和睡眠呼吸暂停患者的传统风险因素及心血管风险的生理生物标志物。
基于社区的参与性研究。
样本包括来自“关注风险评估的心脏策略”(Heart SCORE)研究的795名无既往心血管疾病的参与者。
对参与者进行失眠和睡眠呼吸暂停风险症状评估,以及肥胖、吸烟、久坐不动的生活方式、高血压、血脂异常和糖尿病的存在情况评估。通过B型超声测量基线静息肱动脉直径。共有138名参与者(17.4%)仅符合失眠综合征标准,179名(22.5%)仅睡眠呼吸暂停风险高,95名(11.9%)报告既有失眠综合征又有高睡眠呼吸暂停风险,383名(48.2%)报告既无失眠也无睡眠呼吸暂停症状。仅高睡眠呼吸暂停风险组以及合并失眠和高睡眠呼吸暂停风险组的肥胖、久坐不动的生活方式、高血压以及三种或更多传统心血管风险因素的发生率更高,肱动脉直径显著大于仅失眠组以及无失眠或睡眠呼吸暂停症状的组。高睡眠呼吸暂停风险组与合并组在传统心血管风险因素或肱动脉直径方面未发现差异。
这些发现表明睡眠呼吸暂停是心血管风险的主要促成因素,同时出现的失眠似乎并未增加这一风险。